Evercore is playing a pivotal role as the financial adviser in a landmark deal where Nuvation Bio is set to acquire AnHeart Therapeutics.
This strategic move is designed to catapult Nuvation Bio into the forefront of the global oncology
Evercore is playing a pivotal role as the financial adviser in a landmark deal where Nuvation Bio is set to acquire AnHeart Therapeutics.
This strategic move is designed to catapult Nuvation Bio into the forefront of the global oncology
All the week’s industry events straight to your inbox.
By signing up you agree to our terms of use and privacy policy.
7 Bell Yard, London, England, WC2A 2JR
You will soon receive a Reset Password link
By signing up you agree to terms of use and privacy policy.
Continue with Facebook Continue with Google